Gian(SZ:300709)2021-04-27 16:00Financial Performance - The company's operating revenue for Q1 2021 was ¥417,580,496.05, representing a 57.25% increase compared to ¥265,548,813.01 in the same period last year[9]. - The net profit attributable to shareholders for Q1 2021 was ¥22,471,542.25, up 37.14% from ¥16,386,333.18 in the previous year[9]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 17.89% to ¥15,313,525.58 from ¥18,650,758.15 year-on-year[9]. - Basic and diluted earnings per share increased by 42.86% to ¥0.20 from ¥0.14 in the previous year[9]. - The company's operating revenue for Q1 2021 was CNY 417.58 million, representing a year-on-year increase of 57.25% due to sustained growth in product sales and expanded business scale[25]. - The net profit attributable to shareholders for the same period was CNY 22.47 million, a year-on-year increase of 37.14%[28]. - Operating profit for Q1 2021 was CNY 18,933,864.40, down 30% from CNY 27,115,624.37 in Q1 2020[68]. - Net profit for Q1 2021 reached CNY 23,307,160.48, slightly up from CNY 23,110,053.99 in Q1 2020[68]. - Total comprehensive income for Q1 2021 was CNY 23,797,265.38, compared to CNY 23,110,053.99 in the same period last year[69]. Cash Flow and Assets - The net cash flow from operating activities was negative at -¥31,262,951.58, a decline of 378.31% compared to ¥11,232,990.02 in the same period last year[9]. - Cash and cash equivalents net decrease was CNY 399.84 million, a 1395.78% increase compared to the previous period, influenced by changes in cash flows from operating, investing, and financing activities[26]. - As of March 31, 2021, the company's cash and cash equivalents decreased to ¥416,959,314.16 from ¥869,074,093.91 at the end of 2020, representing a decline of approximately 52%[54]. - The company's trading financial assets increased significantly to ¥370,000,000.00 from ¥101,145,204.00, marking a growth of approximately 266%[54]. - The total current assets amounted to ¥2,027,761,216.08, down from ¥2,097,311,155.56, indicating a decrease of about 3.31%[54]. - The ending cash and cash equivalents balance was CNY 317,335,792.64, down from CNY 258,547,707.93 in the previous period[72]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,884[13]. - The largest shareholder, Wang Mingxi, holds 21.73% of the shares, amounting to 25,111,944 shares[13]. - The company reported a total of 26,826,565 restricted shares at the end of the reporting period[19]. - The major shareholders did not engage in any repurchase transactions during the reporting period[15]. - The company has a total of 10 major shareholders, with significant holdings by private equity funds[15]. Research and Development - Research and development expenses increased to CNY 41.59 million, up 62.66% compared to the previous year, driven by an increase in R&D projects[25]. - The company is committed to increasing R&D investment and improving product quality to address risks related to new product development and process changes[33]. - The company plans to enhance R&D capabilities and expand into new customer segments to mitigate risks associated with customer concentration[33]. Acquisitions and Investments - The company completed a 60% acquisition of Shenzhen Antexin Technology Co., Ltd., which was included in the consolidated financial statements[27]. - The company plans to invest RMB 1.16 billion in real estate located in Changzhou, Jiangsu Province[41]. - The company has completed the acquisition of 60% of Shenzhen Ant Technology Co., Ltd. for RMB 180 million, which has been included in the consolidated financial statements[41]. Risks and Management - The company faces risks from macroeconomic fluctuations and market volatility in downstream industries, which could impact performance[31]. - The company is exposed to exchange rate fluctuation risks, particularly due to a significant portion of revenue being generated from overseas sales[36]. - The company is enhancing its management capabilities to mitigate management risks associated with business diversification and complexity[37]. - The company is closely monitoring national tax policy adjustments to adapt its strategies accordingly[38]. Financial Liabilities - The company's total liabilities increased significantly, with other payables rising by 395.97% to CNY 117.98 million, mainly due to the acquisition of Shenzhen Antexin Technology Co., Ltd.[23]. - Current liabilities amounted to CNY 1,150,189,777.57, compared to CNY 1,063,709,805.71 in the previous year, showing an increase of approximately 8.1%[60]. - The company's total liabilities reached CNY 1,605,101,210.48, up from CNY 1,516,471,856.13, representing a growth of about 5.8%[60].